These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1474171)

  • 1. The stereoselective pharmacokinetics of etodolac in young and elderly subjects, and after cholecystectomy.
    Brocks DR; Jamali F; Russell AS; Skeith KJ
    J Clin Pharmacol; 1992 Nov; 32(11):982-9. PubMed ID: 1474171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etodolac clinical pharmacokinetics.
    Brocks DR; Jamali F
    Clin Pharmacokinet; 1994 Apr; 26(4):259-74. PubMed ID: 8013160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR; Jamali F
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of etodolac enantiomers in the rat after administration of phenobarbital or cimetidine.
    Brocks DR; Jamali F
    Eur J Drug Metab Pharmacokinet; 1992; 17(4):293-9. PubMed ID: 1301359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral bioequivalence: effect of absorption rate on racemic etodolac.
    Boni JR; Korth-Bradley JM; Richards LS; Chiang ST; Hicks DR; Benet LZ
    Clin Pharmacokinet; 2000 Dec; 39(6):459-69. PubMed ID: 11192477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselective HPLC-DAD method for the determination of etodolac enantiomers in tablets, human plasma and application to comparative pharmacokinetic study of both enantiomers after a single oral dose to twelve healthy volunteers.
    Hewala II; Moneeb MS; Elmongy HA; Wahbi AA
    Talanta; 2014 Dec; 130():506-17. PubMed ID: 25159440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective disposition of etodolac enantiomers in synovial fluid.
    Brocks DR; Jamali F; Russell AS
    J Clin Pharmacol; 1991 Aug; 31(8):741-6. PubMed ID: 1831817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of flurbiprofen in man: influence of stereochemistry and age.
    Patel BK; Jackson SH; Swift CG; Hutt AJ
    Xenobiotica; 2003 Oct; 33(10):1043-57. PubMed ID: 14555340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic analysis of enterohepatic circulation of etodolac and effect of hepatic and renal injury on the pharmacokinetics.
    Ogiso T; Kitagawa T; Iwaki M; Tanino T
    Biol Pharm Bull; 1997 Apr; 20(4):405-10. PubMed ID: 9145219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the stereoselective metabolism of the chiral analgesic drug etodolac by high-performance liquid chromatography.
    Becker-Scharfenkamp U; Blaschke G
    J Chromatogr; 1993 Nov; 621(2):199-207. PubMed ID: 8294542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of flurbiprofen and its enantiomers.
    Davies NM
    Clin Pharmacokinet; 1995 Feb; 28(2):100-14. PubMed ID: 7736686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketoprofen pharmacokinetics in the elderly: influence of rheumatic disease, renal function, and dose.
    Skeith KJ; Russell AS; Jamali F
    J Clin Pharmacol; 1993 Nov; 33(11):1052-9. PubMed ID: 8300888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of sustained-release etodolac.
    Benet LZ
    Rheumatol Int; 1993; 13(2 Suppl):S3-5. PubMed ID: 8210922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ketoprofen enantiomers in cholecystectomy patients: influence of probenecid.
    Foster RT; Jamali F; Russell AS
    Eur J Clin Pharmacol; 1989; 37(6):589-94. PubMed ID: 2612555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective pharmacokinetics of etodolac in the rat: tissue distribution, tissue binding, and in vitro metabolism.
    Brocks DR; Jamali F
    J Pharm Sci; 1991 Nov; 80(11):1058-61. PubMed ID: 1839997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective pharmacokinetics of flurbiprofen in humans and rats.
    Jamali F; Berry BW; Tehrani MR; Russell AS
    J Pharm Sci; 1988 Aug; 77(8):666-9. PubMed ID: 3210154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of etodolac in the horse following oral and intravenous administration.
    Davis JL; Papich MG; Morton AJ; Gayle J; Blikslager AT; Campbell NB
    J Vet Pharmacol Ther; 2007 Feb; 30(1):43-8. PubMed ID: 17217400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a stereospecific high-performance liquid chromatography assay to a pharmacokinetic study of etodolac enantiomers in humans.
    Jamali F; Mehvar R; Lemko C; Eradiri O
    J Pharm Sci; 1988 Nov; 77(11):963-6. PubMed ID: 2976091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etodolac kinetics in the elderly.
    Scatina J; Hicks D; Kraml M; Weidler D; Garg D; Sanda M
    Clin Pharmacol Ther; 1986 May; 39(5):550-3. PubMed ID: 2938866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer.
    Haegele KD; Schechter PJ
    Clin Pharmacol Ther; 1986 Nov; 40(5):581-6. PubMed ID: 3769388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.